Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Cooke GS., Pett S., McCabe L., Jones C., Gilson R., Verma S., Ryder SD., Collier JD., Barclay ST., Ala A., Bhagani S., Nelson M., Ch'Ng C., Stone B., Wiselka M., Forton D., McPherson S., Halford R., Nguyen D., Smith D., Ansari A., Dennis E., Hudson F., Barnes EJ., Walker AS.

DOI

10.12688/wellcomeopenres.16594.1

Type

Preprint

Publication Date

29/07/2021

Permalink Original publication